Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma
Sachiyo Yoshio(National Center for Global Health and Medicine), Tatsuya Kanto(National Center for Global Health and Medicine), Tomoharu Yoshizumi(Kyushu University), Shinji Itoh(Kyushu University), Moto Fukai(Hokkaido University), Tomonari Shimagaki(National Hospital Organization Kyushu Cancer Center), Hironari Kawai(National Center for Global Health and Medicine), Masaki Mori(Tokai University), Taiji Yamazoe(National Center for Global Health and Medicine), Shiori Yoshikawa(National Center for Global Health and Medicine), Akinobu Taketomi(Hokkaido University), Ryuki Hashida(Kurume University), Yuzuru Sakamoto(Hokkaido University), Yosuke Osawa(International University of Health and Welfare), Takumi Kawaguchi(Kurume University), Yuichi Yoshida(National Center for Global Health and Medicine), Yuriko Tsutsui(National Center for Global Health and Medicine), Taizo Mori(National Center for Global Health and Medicine)
Cited by 31
Related Papers
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers
|Journal of Thoracic Oncology|2008|424
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424